Nottingham University Hospitals NHS Trust has selected Nervecentre to offer a range of services that include electronic prescription and medication administration (EPMA) and FHIR-based interoperability.
The couple has been working together for the past ten years with the confidence they seek to reach HIMSS level 7.
The latter partnership will see the deployment of a number of new modules in the areas of hospitalization and emergencies, including EPMA, structured clinical documentation, discharge summaries, care plans, fluid balance, clinical photography and FHIR-based interoperability .
The new modules will be rolled out over a 12-month period across Nottingham’s two main locations, City Hospital and Queen’s Medical Center.
Andrew Fearn, director of trusted digital services, said: “Choosing Nervecentre as a partner for this important digital transformation was an easy choice for us, because our doctors demand modern, intuitive and mobile systems.
“Nervecentre has been at the heart of our digital roadmap for many years and has played a crucial role in helping us deliver safe and timely patient care. As we move into the gears of digital maturity and continue our drive toward paperless care, it makes sense that we build around a system that clinicians love and that teams routinely use in both our hospitals and the community ”.
Nottingham has been using Nervecentre’s patient safety solutions since 2010, including sepsis, clinical annotations, patient flow and assessments. In 2015, the trust used money from the NHS England technology fund to deploy Nervecentre electronic observation software.
Paul Volkaerts, founder and CEO of Nervecentre Software, added: “Our goal is to bring EPR systems into the 21st century, by building modern, intuitive, mobile and interoperable systems that clinicians love and do not tolerate.
“NUH has always been an example in the selection and adoption of technology, and its ability to adopt, embed and exploit technology to the fullest is not unsurpassed.”